Action J2AZ34 JAZZ PHARMACEUTICALS PLC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Jazz Pharmaceuticals plc Sao Paulo

Actions

J2AZ34

BRJ2AZBDR009

Marché Fermé - Sao Paulo
Autres places de cotation
 15:17:51 10/05/2024 		Varia. 5j. Varia. 1 janv.
38,72 BRL -0,56% Graphique intraday de Jazz Pharmaceuticals plc -.--% -10,95%
20/06 JAZZ PHARMACEUTICALS PLC : Needham & Co. persiste à l'achat ZM
20/06 Mise à jour sectorielle : Les actions du secteur de la santé sont en baisse avant la cloche jeudi MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
PR
Jazz Pharmaceuticals : 2023 Annual Report
PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)
AQ
Jazz Pharmaceuticals plc - Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer
AQ
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
PR
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
PR
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
PR
Jazz Pharmaceuticals : Corporate Overview
PU
Jazz Pharmaceuticals : Announces First Quarter 2024 Financial Results
PU
Jazz: Q1 Earnings Snapshot
AQ
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
PR
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
PR
Jazz Pharmaceuticals to Present Data across Growing Oncology Pipeline and Portfolio at ASCO 2024
AQ
The PharmaMar Group presents financial results for the first quarter of 2024
AQ
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
PR
Jazz Pharmaceuticals : Zanidatamab R&D Day
PU
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
PR
Agrify Corp Stock Presents Compelling Opportunity As Deal Flow Intensifies ($AGFY)
AQ
Jazz Pharmaceuticals : Corporate Overview
PU
Jazz: Q4 Earnings Snapshot
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action JAZZ
  4. Action J2AZ34
  5. Actualités Jazz Pharmaceuticals plc
  6. Communiqués